Want to see INBS full AI Analyst Report?
Total Valuation
Intelligent Bio Solutions has a market cap or net worth of $6.63M. The enterprise value is $0.11.
Market Cap$6.63M
Enterprise Value$0.11
Share Statistics
Intelligent Bio Solutions has 3,316,803 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,316,803
Owned by Insiders2.73%
Owned by Institutions4.26%
Financial Efficiency
Intelligent Bio Solutions’s return on equity (ROE) is -2.26 and return on invested capital (ROIC) is -176.09%.
Return on Equity (ROE)-2.26
Return on Assets (ROA)-1.04
Return on Invested Capital (ROIC)-176.09%
Return on Capital Employed (ROCE)-1.80
Revenue Per Employee72.68K
Profits Per Employee-214.98K
Employee Count58
Asset Turnover0.35
Inventory Turnover5.17
Valuation Ratios
The current PE Ratio of Intelligent Bio Solutions is ―. Intelligent Bio Solutions’s PEG ratio is 0.00471.
PE Ratio―
PS Ratio0.80
PB Ratio0.61
Price to Fair Value0.61
Price to FCF-0.28
Price to Operating Cash Flow-0.47
PEG Ratio0.00471
Income Statement
In the last 12 months, Intelligent Bio Solutions had revenue of 4.22M and earned -12.43M in profits. Earnings per share was -8.44.
Revenue4.22M
Gross Profit2.05M
Operating Income-12.61M
Pretax Income-12.47M
Net Income-12.43M
EBITDA-11.29M
Earnings Per Share (EPS)-8.44
Cash Flow
In the last 12 months, operating cash flow was -12.08M and capital expenditures -128.57K, giving a free cash flow of -12.20M billion.
Operating Cash Flow-12.08M
Free Cash Flow-12.20M
Free Cash Flow per Share-3.68
Dividends & Yields
Intelligent Bio Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.45
52-Week Price Change-85.23%
50-Day Moving Average2.18
200-Day Moving Average4.19
Relative Strength Index (RSI)38.69
Average Volume (3m)257.56K
Important Dates
Intelligent Bio Solutions upcoming earnings date is Nov 5, 2026, Before Open (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Intelligent Bio Solutions as a current ratio of 1.44, with Debt / Equity ratio of 33.01%
Current Ratio1.44
Quick Ratio1.35
Debt to Market Cap0.54
Net Debt to EBITDA0.19
Interest Coverage Ratio-1.17K
Taxes
In the past 12 months, Intelligent Bio Solutions has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Intelligent Bio Solutions EV to EBITDA ratio is -0.11, with an EV/FCF ratio of -0.10.
EV to Sales0.29
EV to EBITDA-0.11
EV to Free Cash Flow-0.10
EV to Operating Cash Flow-0.10
Balance Sheet
Intelligent Bio Solutions has $3.99M in cash and marketable securities with $1.82M in debt, giving a net cash position of $2.17M billion.
Cash & Marketable Securities$3.99M
Total Debt$1.82M
Net Cash$2.17M
Net Cash Per Share$0.66
Tangible Book Value Per Share$1.69
Margins
Gross margin is 27.71%, with operating margin of -299.11%, and net profit margin of -294.91%.
Gross Margin27.71%
Operating Margin-299.11%
Pretax Margin-295.80%
Net Profit Margin-294.91%
EBITDA Margin-267.94%
EBIT Margin-295.55%
Analyst Forecast
The average price target for Intelligent Bio Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast38.09%
EPS Growth Forecast54.22%